Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Titel:
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Auteur:
Demetri, George D Reichardt, Peter Kang, Yoon-Koo Blay, Jean-Yves Rutkowski, Piotr Gelderblom, Hans Hohenberger, Peter Leahy, Michael von Mehren, Margaret Joensuu, Heikki Badalamenti, Giuseppe Blackstein, Martin Le Cesne, Axel Schöffski, Patrick Maki, Robert G Bauer, Sebastian Nguyen, Binh Bui Xu, Jianming Nishida, Toshirou Chung, John Kappeler, Christian Kuss, Iris Laurent, Dirk Casali, Paolo G